Home/Filings/4/0001062993-22-004978
4//SEC Filing

GUIFFRE CHRISTOPHERD T 4

Accession 0001062993-22-004978

CIK 0001835567other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:41 PM ET

Size

7.6 KB

Accession

0001062993-22-004978

Insider Transaction Report

Form 4
Period: 2022-02-16
GUIFFRE CHRISTOPHERD T
CFO, COO, Treas., & Asst. Sec.
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-16+118,170118,170 total
    Exercise: $4.06Exp: 2032-02-16Common Stock (118,170 underlying)
  • Award

    Restricted Stock Units

    2022-02-16+150,000150,000 total
    Common Stock (150,000 underlying)
Footnotes (3)
  • [F1]25% of the shares underlying the option shall vest on January 14, 2023 and an additional 2.0833 and 1/3% of the shares shall vest on the last day of each calendar month thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
  • [F3]The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025.

Issuer

Pear Therapeutics, Inc.

CIK 0001835567

Entity typeother

Related Parties

1
  • filerCIK 0001219021

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:41 PM ET
Size
7.6 KB